Center Overview The mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases. The DRC accomplishes this mission through Biomedical Research Core services reflecting the evolving needs of diabetes investigators, vibrant Pilot & Feasibility Programs, and a dynamic Enrichment Program. Now in its 40th year of continuous NIDDK funding, this DRC is located at an outstanding research institution with a longstanding tradition of excellence in diabetes investigation. The WUSM DRC Research Base is organized in four Focus Groups: Metabolic Regulation, Islet Biology & Immunology, Prevention & Epidemiology, and Complications. Investigators from each group participate in DRC programs that address the Center's central scientific theme of enhancing approaches across the translational spectrum. There is compelling evidence that the WUSM DRC is successfully pursuing its mission of supporting and enhancing research, including outstanding productivity as measured by both by scientific publications and peer-reviewed funding in diabetes and related research. Our research strategy will build on these accomplishments by: 1. Creating an environment that supports important as well as innovative research in diabetes and related metabolic disorders; 2. Supporting cutting edge basic and clinical research related to the etiology, pathogenesis, prevention and cure of diabetes; 3. Raising awareness and interest in fundamental and clinical diabetes research in addition to enhancing multidisciplinary approaches to diabetes and its complications; and 4. Translating new knowledge in diabetes to improved treatment of patients with diabetes.
Center Overview Diabetes and related metabolic disorders of obesity, insulin resistance, and metabolic syndrome are complex, systemic conditions involving environmental and genetic influences. The infrastructure and support of the Washington University DRC, as well as its nurturing and collaborative nature, are designed to foster multidisciplinary approaches across the translational spectrum to achieve progress in understanding the pathophysiology of these disorders and in developing an infrastructure for developing new treatments, cures and preventive strategies for diabetes and its complications.
| Riek, Amy E; Oh, Jisu; Darwech, Isra et al. (2018) Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes. J Steroid Biochem Mol Biol 177:187-192 |
| Musselman, Laura Palanker; Fink, Jill L; Maier, Ezekiel J et al. (2018) Seven-Up Is a Novel Regulator of Insulin Signaling. Genetics 208:1643-1656 |
| Bittel, Adam J; Bohnert, Kathryn L; Reeds, Dominic N et al. (2018) Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study. JIMD Rep : |
| Peterson, Linda R; Xanthakis, Vanessa; Duncan, Meredith S et al. (2018) Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc 7: |
| Ferguson, Daniel; Blenden, Mitchell; Hutson, Irina et al. (2018) Mouse Embryonic Fibroblasts Protect ob/ob Mice From Obesity and Metabolic Complications. Endocrinology 159:3275-3286 |
| Hampton, Kaia K; Anderson, Katie; Frazier, Hilaree et al. (2018) Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1. Mol Pharmacol 94:665-673 |
| Warren, Junco S; Tracy, Christopher M; Miller, Mickey R et al. (2018) Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart. Proc Natl Acad Sci U S A 115:E7871-E7880 |
| Samovski, Dmitri; Dhule, Pallavi; Pietka, Terri et al. (2018) Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling. Diabetes 67:1272-1284 |
| Adams, Melissa T; Gilbert, Jennifer M; Hinojosa Paiz, Jesus et al. (2018) Endocrine cell type sorting and mature architecture in the islets of Langerhans require expression of Roundabout receptors in ? cells. Sci Rep 8:10876 |
| Funk, Steven D; Bayer, Raymond H; Malone, Andrew F et al. (2018) Pathogenicity of a Human Laminin ?2 Mutation Revealed in Models of Alport Syndrome. J Am Soc Nephrol 29:949-960 |
Showing the most recent 10 out of 654 publications
